A multi-cancer early detection (MCED) test: clinical update for GPs.
作者信息
Save Tanvi, Neal Richard D, Round Thomas
机构信息
School of Life Course & Population Sciences, King's College London, London.
APEx (Exeter Collaboration for Academic Primary Care), Faculty of Health & Life Sciences, University of Exeter, Exeter.
出版信息
Br J Gen Pract. 2024 Jul 25;74(745):380-382. doi: 10.3399/bjgp24X739113. Print 2024 Aug.
Abstract
摘要
相似文献
1
A multi-cancer early detection (MCED) test: clinical update for GPs.一种多癌早期检测（MCED）测试：全科医生的临床最新情况
Br J Gen Pract. 2024 Jul 25;74(745):380-382. doi: 10.3399/bjgp24X739113. Print 2024 Aug.
2
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study.与多癌早期检测测试（PATHFINDER）相关的社会心理影响：一项前瞻性、多中心队列研究。
Lancet Oncol. 2025 Feb;26(2):165-174. doi: 10.1016/S1470-2045(24)00645-4. Epub 2025 Jan 13.
3
Estimating the incremental population health impact of a multi-cancer early detection (MCED) test to complement existing screening among elevated risk populations with multiple cancer risk factors: a mathematical modeling study.评估多癌早期检测（MCED）检测对具有多种癌症风险因素的高危人群中现有筛查进行补充所带来的人群健康增量影响：一项数学建模研究。
BMC Health Serv Res. 2024 Dec 18;24(1):1584. doi: 10.1186/s12913-024-12037-1.
4
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals.建立模型评估将多癌种早期检测（MCED）试验纳入免疫功能低下人群现有癌症筛查计划对人群健康的影响。
Curr Med Res Opin. 2024 Sep;40(9):1577-1587. doi: 10.1080/03007995.2024.2386049. Epub 2024 Aug 17.
5
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.多癌种早期检测试验对英国不同社会经济群体模型化死亡率获益的筛查参与度的影响。
J Epidemiol Community Health. 2024 May 9;78(6):345-353. doi: 10.1136/jech-2023-220834.
6
Multicancer early detection testing: Guidance for primary care discussions with patients.多癌早期检测测试：与患者进行初级保健讨论的指南。
Cancer. 2025 Apr 1;131(7):e35823. doi: 10.1002/cncr.35823.
7
Assessment of the impact of multi-cancer early detection test screening intervals on late-stage cancer at diagnosis and mortality using a state-transition model.使用状态转换模型评估多癌早期检测测试筛查间隔对诊断时晚期癌症和死亡率的影响。
BMJ Open. 2025 May 8;15(5):e086648. doi: 10.1136/bmjopen-2024-086648.
8
Physicians' perception on using a multi-cancer early detection blood test to reduce disparities in cancer screening.医生对使用多癌种早期检测血液检测以减少癌症筛查差异的看法。
J Natl Med Assoc. 2024 Aug;116(4):325-327. doi: 10.1016/j.jnma.2024.07.011. Epub 2024 Jul 15.
9
Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England.有意愿进行基于血液的多癌早期检测（MCED）筛查：英格兰基于人群的横断面调查。
Br J Cancer. 2024 Oct;131(7):1202-1211. doi: 10.1038/s41416-024-02822-4. Epub 2024 Aug 27.
10
Multi-Cancer Early Detection Tests: State of the Art and Implications for Radiologists.多癌早期检测测试：现状及对放射科医生的影响
Radiology. 2025 Jan;314(1):e233448. doi: 10.1148/radiol.233448.
本文引用的文献
1
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.多癌种早期检测试验对英国不同社会经济群体模型化死亡率获益的筛查参与度的影响。
J Epidemiol Community Health. 2024 May 9;78(6):345-353. doi: 10.1136/jech-2023-220834.
2
Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection.多癌种早期检测：癌症早期检测的新前沿。
Annu Rev Med. 2024 Jan 29;75:67-81. doi: 10.1146/annurev-med-050522-033624. Epub 2023 Sep 20.
3
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.英国和威尔士因癌症检查而转诊的有症状患者的多癌早期检测试验（SYMPLIFY）：一项大规模观察性队列研究
Lancet Oncol. 2023 Jul;24(7):733-743. doi: 10.1016/S1470-2045(23)00277-2. Epub 2023 Jun 20.
4
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.基于游离DNA的无症状筛查人群多癌早期检测试验（NHS-Galleri）：一项实用、前瞻性随机对照试验的设计
Cancers (Basel). 2022 Oct 1;14(19):4818. doi: 10.3390/cancers14194818.
5
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.探索者研究：评估一种研究性多癌早期检测测试在临床实践中的实施情况。
Cancers (Basel). 2021 Jul 13;13(14):3501. doi: 10.3390/cancers13143501.
6
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.使用独立验证集对靶向甲基化的多癌种早期检测测试进行临床验证。
Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24.
7
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.基于游离血浆 DNA 的多癌种血液检测的预后意义。
Clin Cancer Res. 2021 Aug 1;27(15):4221-4229. doi: 10.1158/1078-0432.CCR-21-0417. Epub 2021 Jun 4.
8
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?循环肿瘤 DNA（ctDNA）作为一种泛癌种筛查检测手段：它是否终于要面世了？
Clin Chem Lab Med. 2021 Apr 15;59(8):1353-1361. doi: 10.1515/cclm-2021-0171. Print 2021 Jul 27.
9
Liquid biopsy: monitoring cancer-genetics in the blood.液体活检：监测血液中的癌症基因突变。
Nat Rev Clin Oncol. 2013 Aug;10(8):472-84. doi: 10.1038/nrclinonc.2013.110. Epub 2013 Jul 9.
10
Overdiagnosis in cancer.癌症过度诊断。
J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22.
Zotero 插件